The Sickle Cell Association of New Jersey (EIN 800474935) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2009

Legal Domicile

Principal Officer

Mary Bentley LaMar

Phone

9734829070

Tax Period

2024-01-01 to 2024-12-31

The Sickle Cell Association of New Jersey, founded in 2009, is a small nonprofit in the Diseases & Disorders sector that reported $449K in total revenue in fiscal year 2024. Revenue surged 22% from the prior year, signaling strong growth momentum.

Mission

The agency assists individuals and families affected by sickle cell disease through education, support, advocacy and other programs that improve the quality of life.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $448,861

Program Service Revenue $0

Investment Income $1

Other Revenue $0

TOTAL REVENUE $448,862

Expense Breakdown

Grants Paid $0

Salaries & Benefits $278,187

Fundraising Expenses $0

Program Expenses $416,682

Other Expenses $173,959

TOTAL EXPENSES $452,146

Year-over-Year Comparison

	2024	2023	Change
Revenue	$448,862	$368,109	+0.2%
Expenses	$452,146	$432,820	+0.0%
Net Income	$-3,284	$-64,711	-0.9%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

100

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

⚠ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

$55,154

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
Mary Bentley LaMar	Executive Director	50.00	Key Emp	$55,154	$0	$55,154
Joy Elaine Daley	Board Member	1.00	Director	$0	$0	$0
Ansley W LaMar	President	4.00	Officer Director	$0	$0	$0
Beverly Lucas	Secretary	4.00	Officer Director	$0	$0	$0
Vallerie Cleveland	Treasurer	4.00	Officer Director	$0	$0	$0
Deborah Wilson	Board Member	1.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$448,862	$452,146	$40,638	$-3,284
2023	$368,109	$432,820	$41,750	$-64,711
2022	$323,191	$258,133	$116,219	$65,058
2021	$222,245	$181,048	$49,012	$41,197
2020	$195,550	$200,799	$20,096	$-5,249
2019	$215,373	$212,792	$14,003	$2,581

The Sickle Cell Association of New Jersey